)
Marina Kolocha, PharmD, PhD, Director MPLM
Rare Disease Consultant
Consultant
Marina Kolocha has biopharmaceutical expertise spanning more than 20 years, including trusted advisory, executive leadership and integrated lifecycle asset discovery, development, approval, access, and use of over 290 assets for treatment seriously debilitation and life-threatening diseases (SDLT) (72% in pediatrics) in 45 therapeutic classes, resulting in approximately $4.8bn in capital committed to alliances with biotechnology and pharmaceutical partners of all sizes. She is active patient advocate and supported over 40 externally led patient-focused drug development meetings and patients listening sessions.
Sessions
-
23-Jun-202631CTailoring Clinical Trials to Rare Disease Patients’ Experiences
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}